{"id":12784,"date":"2026-02-18T13:51:00","date_gmt":"2026-02-18T13:51:00","guid":{"rendered":"https:\/\/csiag.eu\/?p=12784"},"modified":"2026-02-18T14:26:28","modified_gmt":"2026-02-18T14:26:28","slug":"fotobiomoduliacija-pbm","status":"publish","type":"post","link":"https:\/\/csiag.eu\/lt\/blog\/2026\/02\/18\/photobiomodulation-pbm\/","title":{"rendered":"Fotobiomoduliacija (PBM)"},"content":{"rendered":"<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_87_1 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title\" style=\"cursor:inherit\">Turinys<\/p>\n<span class=\"ez-toc-title-toggle\"><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/csiag.eu\/lt\/blog\/2026\/02\/18\/photobiomodulation-pbm\/#Einleitung\" >\u012evadas<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/csiag.eu\/lt\/blog\/2026\/02\/18\/photobiomodulation-pbm\/#Indikationen_auf_einen_Blick\" >Indikacijos i\u0161 pirmo \u017evilgsnio<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/csiag.eu\/lt\/blog\/2026\/02\/18\/photobiomodulation-pbm\/#Haut_Wundheilung_Kollagen_660_nm\" >oda, \u017eaizd\u0173 gijimas ir kolagenas (660 nm)<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/csiag.eu\/lt\/blog\/2026\/02\/18\/photobiomodulation-pbm\/#Ubergreifende_Reviews_Mechanismen\" >I\u0161samios ap\u017evalgos ir mechanizmai<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/csiag.eu\/lt\/blog\/2026\/02\/18\/photobiomodulation-pbm\/#Kollagensynthese_Hautverjungung\" >Kolageno sintez\u0117 ir odos atjauninimas<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/csiag.eu\/lt\/blog\/2026\/02\/18\/photobiomodulation-pbm\/#Klinische_Studien_Wundheilung_JAAD\" >Klinikiniai tyrimai \u017daizd\u0173 gijimas (JAAD)<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/csiag.eu\/lt\/blog\/2026\/02\/18\/photobiomodulation-pbm\/#Muskeln_Sport_Rehabilitation_850_nm\" >Raumenys, sportas ir reabilitacija (850 nm)<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/csiag.eu\/lt\/blog\/2026\/02\/18\/photobiomodulation-pbm\/#Skelettmuskelregeneration\" >Skeleto raumen\u0173 regeneracija<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/csiag.eu\/lt\/blog\/2026\/02\/18\/photobiomodulation-pbm\/#Meta-Analysen_Sportleistung_Muskelkater\" >Sporto rezultat\u0173 ir raumen\u0173 skausmingumo metaanaliz\u0117s<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/csiag.eu\/lt\/blog\/2026\/02\/18\/photobiomodulation-pbm\/#Gehirn_Kognition_Neurologie_810%E2%80%931064_nm\" >Smegenys, pa\u017einimas ir neurologija (810-1 064 nm)<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/csiag.eu\/lt\/blog\/2026\/02\/18\/photobiomodulation-pbm\/#Mechanismen_allgemeine_Wirkungen\" >Mechanizmai ir bendras poveikis<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/csiag.eu\/lt\/blog\/2026\/02\/18\/photobiomodulation-pbm\/#Alzheimer_Demenz\" >Alzheimerio liga ir demencija<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/csiag.eu\/lt\/blog\/2026\/02\/18\/photobiomodulation-pbm\/#TBI_Entgiftung_1064_nm\" >TBI ir detoksikacija (1 064 nm)<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/csiag.eu\/lt\/blog\/2026\/02\/18\/photobiomodulation-pbm\/#Schmerzmanagement\" >Skausmo valdymas<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-15\" href=\"https:\/\/csiag.eu\/lt\/blog\/2026\/02\/18\/photobiomodulation-pbm\/#Ubergreifende_Reviews\" >I\u0161samios ap\u017evalgos<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-16\" href=\"https:\/\/csiag.eu\/lt\/blog\/2026\/02\/18\/photobiomodulation-pbm\/#Fibromyalgie\" >Fibromialgija<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-17\" href=\"https:\/\/csiag.eu\/lt\/blog\/2026\/02\/18\/photobiomodulation-pbm\/#Kniearthrose_Tendinopathie\" >Kelio osteoartritas ir tendinopatija<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-18\" href=\"https:\/\/csiag.eu\/lt\/blog\/2026\/02\/18\/photobiomodulation-pbm\/#Neuropathischer_Schmerz\" >Neuropatinis skausmas<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-19\" href=\"https:\/\/csiag.eu\/lt\/blog\/2026\/02\/18\/photobiomodulation-pbm\/#Augenheilkunde_AMD\" >Oftalmologija (AMD)<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-20\" href=\"https:\/\/csiag.eu\/lt\/blog\/2026\/02\/18\/photobiomodulation-pbm\/#Altersbedingte_Makuladegeneration\" >Su am\u017eiumi susijusi geltonosios d\u0117m\u0117s degeneracija<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-21\" href=\"https:\/\/csiag.eu\/lt\/blog\/2026\/02\/18\/photobiomodulation-pbm\/#Onkologie_Mukositis\" >Onkologija ir mukozitas<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-22\" href=\"https:\/\/csiag.eu\/lt\/blog\/2026\/02\/18\/photobiomodulation-pbm\/#Leitlinien\" >Gair\u0117s<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-23\" href=\"https:\/\/csiag.eu\/lt\/blog\/2026\/02\/18\/photobiomodulation-pbm\/#Chemotherapie-induzierte_Mukositis\" >Chemoterapijos sukeltas mukozitas<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-24\" href=\"https:\/\/csiag.eu\/lt\/blog\/2026\/02\/18\/photobiomodulation-pbm\/#Kopf-Hals-Karzinome_Strahlentherapie\" >Galvos ir kaklo v\u0117\u017eys ir radioterapija<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-25\" href=\"https:\/\/csiag.eu\/lt\/blog\/2026\/02\/18\/photobiomodulation-pbm\/#Immunsystem_Entzundung\" >Imunin\u0117 sistema ir u\u017edegimas<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-26\" href=\"https:\/\/csiag.eu\/lt\/blog\/2026\/02\/18\/photobiomodulation-pbm\/#Immunmodulation\" >Imunomoduliacija<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-27\" href=\"https:\/\/csiag.eu\/lt\/blog\/2026\/02\/18\/photobiomodulation-pbm\/#Klinische_Empfehlungen\" >Klinikin\u0117s rekomendacijos<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-28\" href=\"https:\/\/csiag.eu\/lt\/blog\/2026\/02\/18\/photobiomodulation-pbm\/#Allgemeine_Dosierungsregeln_Konsensus\" >Bendrosios dozavimo taisykl\u0117s (bendru sutarimu)<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-29\" href=\"https:\/\/csiag.eu\/lt\/blog\/2026\/02\/18\/photobiomodulation-pbm\/#Evidenzstarke_nach_Bereich\" >\u012erodym\u0173 stiprumas pagal sritis<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-30\" href=\"https:\/\/csiag.eu\/lt\/blog\/2026\/02\/18\/photobiomodulation-pbm\/#Kontakt_zu_PBM-Anwendern_%E2%80%93_Arzte_Kliniken\" >Ry\u0161iai su PBM naudotojais - gydytojais \/ klinikomis<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-31\" href=\"https:\/\/csiag.eu\/lt\/blog\/2026\/02\/18\/photobiomodulation-pbm\/#Augenheilkunde_%E2%80%93_Trockene_AMD_Makuladegeneration\" >Oftalmologija - sausoji AMD (geltonosios d\u0117m\u0117s degeneracija)<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-32\" href=\"https:\/\/csiag.eu\/lt\/blog\/2026\/02\/18\/photobiomodulation-pbm\/#Onkologie_%E2%80%93_Orale_Mukositis_Chemo-Strahlentherapiefolge\" >Onkologija - burnos gleivin\u0117s u\u017edegimas (chemoterapijos ir (arba) spindulin\u0117s terapijos pasekm\u0117)<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-33\" href=\"https:\/\/csiag.eu\/lt\/blog\/2026\/02\/18\/photobiomodulation-pbm\/#Dermatologie_%E2%80%93_Haut_Wundheilung_Akne_Psoriasis\" >Dermatologija - oda, \u017eaizd\u0173 gijimas, spuogai, psoriaz\u0117<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-34\" href=\"https:\/\/csiag.eu\/lt\/blog\/2026\/02\/18\/photobiomodulation-pbm\/#Zahnmedizin_MKG-Chirurgie\" >Odontologija \/ veido ir \u017eandikauli\u0173 chirurgija<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-35\" href=\"https:\/\/csiag.eu\/lt\/blog\/2026\/02\/18\/photobiomodulation-pbm\/#Neurologie_Psychiatrie_%E2%80%93_Alzheimer_TBI_Depression_fruhe_Phase\" >Neurologija \/ psichiatrija - Alzheimerio liga, TBI, depresija (ankstyvoji stadija)<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-36\" href=\"https:\/\/csiag.eu\/lt\/blog\/2026\/02\/18\/photobiomodulation-pbm\/#Allgemeine_Suchwerkzeuge\" >Bendrieji paie\u0161kos \u012frankiai<\/a><\/li><\/ul><\/li><\/ul><\/nav><\/div>\n<span class=\"span-reading-time rt-reading-time\" style=\"display: block;\"><span class=\"rt-label rt-prefix\">Skaitymo laikas<\/span> <span class=\"rt-time\"> 12<\/span> <span class=\"rt-label rt-postfix\">minut\u0117s<\/span><\/span>\n<p class=\"wp-block-paragraph\">I\u0161sami 2023-2025 m. tyrimo ap\u017evalga<\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Einleitung\"><\/span>\u012evadas<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Fotobiomoduliacija (PBM), dar \u017einoma kaip \u017eemo lygio lazerio terapija (LLLT), yra neinvazinis gydymo metodas, kai tam tikro bangos ilgio \u0161viesa stimuliuoja biologinius procesus gyvuose audiniuose.<br>Pagrindinis mechanizmas - foton\u0173 absorbcija mitochondrijos fotoakceptoriuje <em>Citochromo c oksidaz\u0117<\/em> (CCO), kuri yra <em>ATP sintez\u0117<\/em> moduliuoja reaktyvi\u0105sias deguonies r\u016b\u0161is ir sukelia l\u0105steli\u0173 regeneracijos proces\u0173 kaskad\u0105.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Terapijai svarbus \u201eoptinis langas\u201c yra nuo 600 iki 1100 nm. Trys klini\u0161kai ypa\u010d svarb\u016bs bangos ilgiai:<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>660 nm<\/strong><br>\u012esiskverbimo gylis 1-10 mm, galios tankis 6-50 mW\/cm\u00b2<br>Idealiai tinka odai, \u017eaizdoms ir pavir\u0161iniams audiniams gydyti.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>850 nm<\/strong><br>\u012esiskverbimo gylis iki 50 mm, galios tankis 50-100 mW\/cm\u00b2<br>Tinka raumenims, s\u0105nariams ir gilesn\u0117ms strukt\u016broms.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>1 050-1 064 nm<\/strong><br>Gilus \u012fsiskverbimas \u012f audinius, galios tankis 25-285 mW\/cm\u00b2 (transkranijinis)<br>Aktualu neurologijos, smegen\u0173 ir oftalmologijos srityse.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Pagrindinis doz\u0117s nustatymo principas <em>Arndto ir \u0160ulco kreiv\u0117<\/em> (Hormez\u0117):<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Per ma\u017eas \u0161viesos kiekis neturi jokio poveikio, o optimali doz\u0117 stimuliuoja<\/li>\n\n\n\n<li>Per didelis j\u0173 kiekis turi slopinam\u0105j\u012f arba l\u0105steles \u017ealojant\u012f poveik\u012f.<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">\u0160is dvifazis ry\u0161ys paai\u0161kina, kod\u0117l s\u0117kmingam gydymui labai svarbus tinkamas galios ir energijos tankis.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Indikationen_auf_einen_Blick\"><\/span>Indikacijos i\u0161 pirmo \u017evilgsnio<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Toliau pateiktoje lentel\u0117je apibendrinti klinikiniuose tyrimuose naudoti parametrai (bangos ilgis, galios tankis, energijos tankis, trukm\u0117, da\u017enis) kiekvienai gydymo sri\u010diai. <br>\u0160altiniai: Hamblin\/Harvardas (<a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC8355782\/\" target=\"_blank\" rel=\"noreferrer noopener\">PMC8355782<\/a>), <a href=\"https:\/\/waltpbm.org\/\" target=\"_blank\" rel=\"noopener\">WALT gair\u0117s<\/a>, klinikiniai tyrimai 2020-2025 m.<\/p>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><td><strong>Indikacija<\/strong><\/td><td><strong>Bangos ilgis<\/strong><\/td><td><strong>Galios tankis<\/strong><\/td><td><strong>Energijos tankis<\/strong><\/td><td><strong>Trukm\u0117 \/ sesija<\/strong><\/td><td><strong>Da\u017enis<\/strong><\/td><\/tr><\/thead><tbody><tr><td>Oda \/ Kolagenas<\/td><td>660 nm<\/td><td>6-50 mW\/cm\u00b2<\/td><td>8-16 J\/cm\u00b2<\/td><td>10-21 min.<\/td><td>2-3\u00d7 per savait\u0119<\/td><\/tr><tr><td>\u017daizd\u0173 gijimas<\/td><td>630-660 nm<\/td><td>10-50 mW\/cm\u00b2<\/td><td>4-15 J\/cm\u00b2<\/td><td>7-20 min.<\/td><td>kasdien - 3 kartus per savait\u0119<\/td><\/tr><tr><td>Raumen\u0173 regeneracija<\/td><td>808-850 nm<\/td><td>50-100 mW\/cm\u00b2<\/td><td>10-30 J\/cm\u00b2<\/td><td>5-15 min.<\/td><td>tiesiogiai prie\u0161 ir po sporto<\/td><\/tr><tr><td>L\u0117tinis skausmas<\/td><td>630-905 nm<\/td><td>40-100 mW\/cm\u00b2<\/td><td>4-10 J\/cm\u00b2<\/td><td>10-20 min.<\/td><td>3\u00d7 per savait\u0119, 6-12 savai\u010di\u0173.<\/td><\/tr><tr><td>Fibromialgija<\/td><td>630-1 100 nm (visas k\u016bnas)<\/td><td>kintamasis<\/td><td>1-150 J\/cm\u00b2<\/td><td>15-30 min.<\/td><td>2-3 kartus per savait\u0119, 4-6 savaites.<\/td><\/tr><tr><td>Kelio osteoartritas<\/td><td>630-850 nm<\/td><td>40-80 mW\/cm\u00b2<\/td><td>4-10 J\/cm\u00b2<\/td><td>10-20 min.<\/td><td>3\u00d7 per savait\u0119<\/td><\/tr><tr><td>Smegenys \/ Pa\u017einimas<\/td><td>810-1064 nm (transkranijinis)<\/td><td>25-285 mW\/cm\u00b2<\/td><td>20-60 J\/cm\u00b2<\/td><td>10-20 min.<\/td><td>3\u00d7 per savait\u0119<\/td><\/tr><tr><td>AMD \/ Akis<\/td><td>590 + 660 + 850 nm<\/td><td>0,3-15 \u03bcW\/cm\u00b2 (tinklain\u0117)<\/td><td>Labai ma\u017eas<\/td><td>3-10 min. per seans\u0105<\/td><td>Nuo 3\u00d7 per savait\u0119 iki kasdien<\/td><\/tr><tr><td>Mukozitas (onkologija)<\/td><td>630-660 nm<\/td><td>10-25 mW\/cm\u00b2<\/td><td>2-6 J\/cm\u00b2<\/td><td>3-5 min. \/ ta\u0161kas<\/td><td>kasdien gydymo metu<\/td><\/tr><tr><td>Imunomoduliacija \/ u\u017edegimas<\/td><td>650-950 nm<\/td><td>kintamasis<\/td><td>1-10 J\/cm\u00b2<\/td><td>5-15 min.<\/td><td>3\u00d7 per savait\u0119<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<p class=\"wp-block-paragraph\"><em>Galios tankis = ap\u0161vita (mW\/cm\u00b2) audinio pavir\u0161iuje.<\/em><br><em>Energijos tankis = spinduliuot\u0117s srautas (J\/cm\u00b2) per seans\u0105.<\/em><br><em>AMD: tinklain\u0117s ap\u0161vitos vert\u0117s yra gerokai ma\u017eesn\u0117s nei odos pavir\u0161iaus vert\u0117s.<\/em><br><em><strong>U\u017euomina<\/strong>Vieningo tarptautinio standarto n\u0117ra - vert\u0117s atspindi bendr\u0105 sutarim\u0105, pasiekt\u0105 atlikus metaanalizes ir WALT rekomendacijas.<\/em><\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Haut_Wundheilung_Kollagen_660_nm\"><\/span>oda, \u017eaizd\u0173 gijimas ir kolagenas (660 nm)<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">660 nm raudon\u0105 \u0161vies\u0105 ypa\u010d veiksmingai sugeria odos chromoforai ir ji aktyvina kolageno sintez\u0119 fibroblastuose, reguliuodama COL1A1 ir COL3A1 gen\u0173 rai\u0161k\u0105, taip pat MMP-9 ir NO i\u0161siskyrim\u0105. \u012esiskverbimo gylis: 1-10 mm (epidermis, derma, poodis). Dvifazis doz\u0117s modelis ypa\u010d ry\u0161kus odos audiniuose: didesnis nei 20 J\/cm\u00b2 energijos tankis gali sukelti oksidacin\u012f stres\u0105 ir atvirk\u0161tin\u0119 kolageno stimuliacij\u0105.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Parametrai<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Bangos ilgis 660 nm (taip pat 630-680 nm)<\/li>\n\n\n\n<li>Galios tankis 6-50 mW\/cm\u00b2 (LED: 6-30; lazeris: 30-50)<\/li>\n\n\n\n<li>Energijos tankis 8-16 J\/cm\u00b2 (optimalus)<\/li>\n\n\n\n<li>Trukm\u0117 10-21 min | 3 kartus per savait\u0119<\/li>\n\n\n\n<li>Ne ma\u017eiau kaip 8 savait\u0117s odos atjauninimui; 4 savait\u0117s \u017eaizd\u0173 gijimui.<\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Ubergreifende_Reviews_Mechanismen\"><\/span>I\u0161samios ap\u017evalgos ir mechanizmai<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Nuo \u0161viesos iki gydymo: fotobiomoduliacin\u0117 terapija medicinos disciplinose<\/strong><br><em>Journal of Translational Medicine (2025)<\/em><a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC12751248\/\" target=\"_blank\" rel=\"noopener\"> Visas tekstas \/ PubMed<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">I\u0161sami fotofizikos, mitochondrij\u0173 biologijos ir klinikin\u0117s reabilitacijos ap\u017evalga. PBM, kurio bangos ilgis 600-1 100 nm, suaktyvina padid\u0117jusi\u0105 ATP sintez\u0119 ir kontroliuojam\u0105 ROS signalizacij\u0105 per CCO, kuri aktyvuoja transkripcijos veiksnius (NF-\u03baB, AP-1, HIF-1\u03b1) ir reguliuoja augimo veiksnius (TGF-\u03b2, VEGF, IGF-1). Audini\u0173 lygmeniu skatinama fibroblast\u0173 ir keratinocit\u0173 proliferacija, makrofag\u0173 poliarizacija ir kolageno sintez\u0117. Svarbiausia rekomenduojama doz\u0117 audiniams, kuriuose yra ma\u017eai mitochondrij\u0173 (oda, sausgysl\u0117s): Energijos tankis &lt; 100 mW\/cm\u00b2, energijos tankis 4-10 J\/cm\u00b2 tiksliniame audinyje.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>\u0160viesos galios atskleidimas odai: i\u0161sami fotobiomoduliacijos ap\u017evalga<\/strong><br><em>Int. J. Mol. Sci. (2024)<\/em> <a href=\"https:\/\/www.mdpi.com\/1422-0067\/25\/8\/4483\" target=\"_blank\" rel=\"noopener\">Visas tekstas \/ PubMed<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Klinikini\u0173 tyrim\u0173, atlikt\u0173 per 6 metus, ap\u017evalga apie PBM dermatologijoje. Da\u017eniausiai naudotas 630-950 nm bangos ilgis. Optimalus odos atjauninimui: 630-660 nm, 6-50 mW\/cm\u00b2, 8-16 J\/cm\u00b2, 3 kartus per savait\u0119. Bikinis dvifazis efektas: geriausi rezultatai, naudojant vidutines-vidutines dozes; per didel\u0117s doz\u0117s (&gt;20 J\/cm\u00b2 ant odos pavir\u0161iaus) gali slopinti kolageno sintez\u0119, u\u017euot j\u0105 skatinusios.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Kollagensynthese_Hautverjungung\"><\/span>Kolageno sintez\u0117 ir odos atjauninimas<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>\u017demo lygio \u0161viesos terapijos optimizavimas odos atjauninimui<\/strong><br><em>SCIRP (2025 M.)<\/em> <a href=\"https:\/\/www.scirp.org\/journal\/paperinformation?paperid=142513\" target=\"_blank\" rel=\"noopener\">Visas tekstas \/ PubMed<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">RCT (su padalytu pavir\u0161iumi) su 830 nm + 633 nm \u0161viesos diodu. Parametrai: 6,4 mW\/cm\u00b2, 8,05 J\/cm\u00b2, 21 minut\u0117 per seans\u0105, 3 kartus per savait\u0119 4 savaites. \u017denklus rauk\u0161li\u0173 suma\u017e\u0117jimas ir pager\u0117j\u0119s odos elastingumas. Pagrindin\u0117 i\u0161vada: 3 seansai per savait\u0119 buvo veiksmingesni nei 2 - seans\u0173 da\u017enis tur\u0117jo didel\u0119 \u012ftak\u0105 rezultatui.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Odos kolageno metabolizmo reguliavimas naudojant 660 nm \u0161viesos diod\u0105<\/strong><br><em>Journal of Investigative Dermatology (klasikinis tyrimas)<\/em><a href=\"https:\/\/www.sciencedirect.com\/science\/article\/pii\/S0022202X15341749\" target=\"_blank\" rel=\"noopener\"> Visas tekstas \/ PubMed<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Parametrai<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>660 nm, impulsinis (nuosekli\u0173j\u0173 impuls\u0173 re\u017eimas LED)<\/li>\n\n\n\n<li>11 susitikim\u0173<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Rezultatai<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>+31% 1 tipo prokolagenas<\/li>\n\n\n\n<li>-18% MMP-1 audini\u0173 biopsijose.<\/li>\n\n\n\n<li>&gt;90% tiriam\u0173j\u0173 rauk\u0161li\u0173 gylis suma\u017e\u0117jo.<\/li>\n\n\n\n<li>Fotobiologiniam veiksmingumui lemiam\u0105 reik\u0161m\u0119 tur\u0117jo nuosekli\u0173 impuls\u0173 modelis (ne i\u0161tisin\u0117 banga).<\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Klinische_Studien_Wundheilung_JAAD\"><\/span>Klinikiniai tyrimai \u017daizd\u0173 gijimas (JAAD)<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Fotobiomoduliacijos CME II dalis: Klinikinis pritaikymas dermatologijoje<\/strong><br><em>Amerikos dermatologijos akademijos \u017eurnalas (2024)<\/em> <a href=\"https:\/\/www.jaad.org\/article\/S0190-9622(24)00187-7\/fulltext\" target=\"_blank\" rel=\"noopener\">Visas tekstas \/ PubMed<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">&gt;20 ekspert\u0173 konsensusas (JAAD). Diabetini\u0173 op\u0173 parametrai (\u012frodym\u0173 lygis IA): 630-670 nm, 10-50 mW\/cm\u00b2, 2-6 J\/cm\u00b2, kasdien arba 3 kartus per savait\u0119 iki \u017eaizdos u\u017edarymo. 12 RCT metaanaliz\u0117: opos plotas -30,9%, -4,2 cm\u00b2, palyginti su kontroliniu tyrimu. Teigiama \u012ftaka visoms \u017eaizd\u0173 gijimo faz\u0117ms (u\u017edegiminei, proliferacinei, remodeliavimo).<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>PBM terapijos (660 nm) poveikis \u017eaizd\u0173, u\u017ekr\u0117st\u0173 auksiniu stafilokoku, gijimui<\/strong><br><em>Fotobiomodulis Photomed Laser Surg. (2020)<\/em> <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/32466696\/\" target=\"_blank\" rel=\"noopener\">Visas tekstas \/ PubMed<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Tyrimas su gyv\u016bnais: 660 nm, 35 min. per dien\u0105, 7 dienas. \u017dymiai ma\u017eesn\u0117s \u017eaizdos (p &lt; 0,01), daugiau granuliuojan\u010dio audinio, did\u017eiausias kolageno kiekis (3+ laipsnio). PCNA proliferacijos \u017eymenys reik\u0161mingai padid\u0117jo. Pastaba: intensyvumas s\u0105moningai palaikomas ma\u017eas - infekuotoms \u017eaizdoms ypa\u010d svarbu nevir\u0161yti doz\u0117s (&lt; 15 J\/cm\u00b2).<\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Muskeln_Sport_Rehabilitation_850_nm\"><\/span>Raumenys, sportas ir reabilitacija (850 nm)<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Artim\u0173j\u0173 infraraudon\u0173j\u0173 spinduli\u0173 850 nm \u0161viesa prasiskverbia iki 50 mm gylio. Remiantis metaanalize (Baroni ir kt., 2019), optimalus parametras raumenims taikyti yra 810 nm, 100 mW\/cm\u00b2, 30 J\/cm\u00b2 - treniruotiems sportininkams i\u0161matuotas 15% j\u0117gos prieaugis. Jei doz\u0117s yra per didel\u0117s (&gt;50 J\/cm\u00b2, &gt;200 mW\/cm\u00b2), poveikis suma\u017e\u0117ja. Leal-Junior ir kt. tyrime (2011) nustatyta, kad optimali 810 nm doz\u0117 yra 30 J i\u0161 viso (ne J\/cm\u00b2) per 6 raumen\u0173 ta\u0161kus prie\u0161 treniruot\u0119.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Parametrai<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Bangos ilgis 808-850 nm<\/li>\n\n\n\n<li>Galios tankis 50-100 mW\/cm\u00b2 (lazeris); 30-150 mW\/cm\u00b2 (LED skydelis)<\/li>\n\n\n\n<li>Energijos tankis 10-30 J\/cm\u00b2 (sportininkams); 6-10 J\/cm\u00b2 (reabilitacijai)<\/li>\n\n\n\n<li>Trukm\u0117 5-15 min. vienai raumen\u0173 grupei<br>Naudokite prie\u0161 pat treniruot\u0119 arba po jos<\/li>\n\n\n\n<li>3-7\u00d7 per savait\u0119 intensyvioms treniruot\u0117ms; 2-3\u00d7 per savait\u0119 reabilitacijai<\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Skelettmuskelregeneration\"><\/span>Skeleto raumen\u0173 regeneracija<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>PBMT skeleto raumen\u0173 regeneracijoje: i\u0161sami ap\u017evalga<\/strong><br><em>Fotodiagnostika ir fotodinamin\u0117 terapija (2025)<\/em> <a href=\"https:\/\/www.sciencedirect.com\/science\/article\/pii\/S1572100025001668\" target=\"_blank\" rel=\"noopener\">Visas tekstas \/ PubMed<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Pagrindinis tyrimas (Baroni 2019): 810 nm, 100 mW\/cm\u00b2, 30 J\/cm\u00b2, 6 raumen\u0173 ta\u0161kai \u2192 15% j\u0117gos padid\u0117jimas sportininkams. IL-6 suma\u017e\u0117jimas 40% su prevenciniu PBM (5 J\/cm\u00b2 ant \u017eiurki\u0173 blauzdikaulio). \u012esp\u0117jimas: tyrim\u0173 su gyv\u016bnais parametrai (pvz., 5 J\/cm\u00b2) n\u0117ra tiesiogiai pritaikomi \u017emon\u0117ms - \u017emogaus keturgalviams \u0161launies raumenims reikia didesnio energijos tankio d\u0117l didesnio audini\u0173 gylio.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>PBM \u017emogaus raumeniniame audinyje: prana\u0161umas sportiniuose rezultatuose?<\/strong><br><em>J. Biophotonics (PMC) (2016)<\/em> <a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC5167494\/\" target=\"_blank\" rel=\"noopener\">Visas tekstas \/ PubMed<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Sistemin\u0117 vis\u0173 RCT (1b lygis) ir atvejo-kontrol\u0117s tyrim\u0173 (3b lygis) ap\u017evalga. Veiksmingiausi parametrai, taikomi bicepsui: 810-850 nm, 50-100 mW\/cm\u00b2, 10-30 J\/cm\u00b2. Veiksmingiausi keturgalvio raumens (didesnis raumuo, gilesni audiniai) parametrai: reikia didesn\u0117s energijos, pirmenyb\u0117 teikiama klasteriniams aplikatoriams (5 diodai). PBM taikymas prie\u0161 treniruot\u0119 yra bent jau lygiavertis, da\u017enai prana\u0161esnis u\u017e taikym\u0105 po treniruot\u0117s j\u0117gos rodikliams.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Meta-Analysen_Sportleistung_Muskelkater\"><\/span>Sporto rezultat\u0173 ir raumen\u0173 skausmingumo metaanaliz\u0117s<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Fotomoduliacin\u0117s terapijos poveikis DOMS: sistemin\u0117 ap\u017evalga ir metaanaliz\u0117<\/strong><br><em>MDPI JFMK (2025)<\/em> <a href=\"https:\/\/www.mdpi.com\/2411-5142\/10\/3\/277\" target=\"_blank\" rel=\"noopener\">Visas tekstas \/ PubMed<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">14 tyrim\u0173, bangos ilgiai 660-950 nm, 1-6 raumen\u0173 ta\u0161kai. Optimalus DOMS ma\u017einimas: 830-850 nm, 50-100 mW\/cm\u00b2, 6-10 J\/cm\u00b2 vienam ta\u0161kui, i\u0161 karto po treniruot\u0117s. Reik\u0161mingas VAS skausmo suma\u017e\u0117jimas, palyginti su placebu; teigiamas poveikis raumen\u0173 j\u0117gos i\u0161laikymui.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Ar PBM prie\u0161 treniruot\u0119 gali pagerinti raumen\u0173 i\u0161tverm\u0119 ir paskatinti atsigavim\u0105? Metaanaliz\u0117<\/strong><br><em>Lazeriai medicinos moksle (2024)<\/em> <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/38758297\/\" target=\"_blank\" rel=\"noopener\">Visas tekstas \/ PubMed<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Kreatinkinaz\u0117s kiekis suma\u017e\u0117jo 77,56 vienetais (95%-KI: nuo -112,67 iki -42,44, p &lt; 0,01). Veiksmingiausi parametrai: 810 nm bangos ilgis, 200 mW bendra galia, 30 J bendra energija \u012f 6 keturgalvio raumens ta\u0161kus. Dvifaz\u0117 i\u0161vada: 50 J bendros energijos buvo ma\u017eiau veiksminga nei 30 J - ai\u0161kus Horm\u0117jo\/Arndto-\u0160ulco kreiv\u0117s pavyzdys.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>PBM prie\u0161 pratybas (810 nm): Optimali raumen\u0173 atsigavimo galia<\/strong><br><em>\"Photomed Laser Surg\" (2017)<\/em> <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/29099680\/\" target=\"_blank\" rel=\"noopener\">Visas tekstas \/ PubMed<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">RCT su 28 futbolo sportininkais. Lyginta 100, 200 ir 400 mW galia vienam diodui (5 diodai, 810 nm). Rezultatas: 100 mW vienam diodui (i\u0161 viso 500 mW) buvo optimalus. Didesn\u0117s galios (200, 400 mW) rezultatai nebuvo geresni arba net blogesni - klasikinis pavyzdys: didesnis galios tankis n\u0117ra automati\u0161kai geresnis.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>PBM, IPC ir NMES poveikis raumen\u0173 atsigavimui: sistemin\u0117 ap\u017evalga<\/strong><br><em>Journal of Bodywork and Movement Therapies (2025)<\/em> <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/40954632\/\" target=\"_blank\" rel=\"noopener\">Visas tekstas \/ PubMed<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">19 RCT, 672 dalyviai. PBM prie\u0161 treniruot\u0119 suma\u017eino skausm\u0105 -12,27 balo (95%-KI -18,14 iki -6,40; I\u00b2 = 48%). PBM buvo vienintelis metodas (lyginant su IPC ir NMES), kuris dav\u0117 reik\u0161ming\u0105 naud\u0105. Rekomenduojami parametrai: 810-850 nm, 50-100 mW\/cm\u00b2, 6-10 J\/cm\u00b2.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Gehirn_Kognition_Neurologie_810%E2%80%931064_nm\"><\/span>Smegenys, pa\u017einimas ir neurologija (810-1 064 nm)<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Transkranijinis PBM turi \u012fveikti kelet\u0105 biologini\u0173 barjer\u0173 (galvos oda, kaukol\u0117s kaulai, smegen\u0173 dangalai, smegen\u0173 skystis, smegen\u0173 \u017eiev\u0117). Tod\u0117l reikiamas galios tankis yra gerokai didesnis nei pavir\u0161inio naudojimo atveju. 2024 m. sistemin\u0117je ap\u017evalgoje (97 tyrimai, 2133 \u0161altiniai) nustatyta: tyrimuose paprastai naudojama ~250 mW\/cm\u00b2 pavir\u0161iaus - i\u0161 j\u0173 tik dalis pasiekia smegen\u0173 audin\u012f. Kortikaliniams neuronams: optimali ATP gamyba esant 25 mW\/cm\u00b2, 3 J\/cm\u00b2. Mitochondrij\u0173 pa\u017eeidimai atsirado jau esant 30 J\/cm\u00b2 (per didel\u0117 doz\u0117 = slopinanti).<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Parametrai<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Bangos ilgis 810 nm (pa\u017einimas\/Alzheimerio liga), 1064 nm (gilus \u012fsiskverbimas\/TBI)<\/li>\n\n\n\n<li>Galingumo tankis 25-285 mW\/cm\u00b2 galvos odoje (tikslinis audinys: \u017eiev\u0117 gauna tik dal\u012f \u0161ios galios)<\/li>\n\n\n\n<li>Energijos tankis 20-60 J\/cm\u00b2 (pavir\u0161ius); 3 J\/cm\u00b2 tiksliniame audinyje (neuronai)<\/li>\n\n\n\n<li>Trukm\u0117 10-20 min. | 3 kartus per savait\u0119 (12 savai\u010di\u0173 Alzheimerio liga sergan\u010di\u0173 pacient\u0173 RCT)<\/li>\n\n\n\n<li>Kognityviniam poveikiui pasireik\u0161ti - ma\u017eiausiai 8-12 savai\u010di\u0173; \u016bminis poveikis nuo 1-2 savai\u010di\u0173, jei tai TBI.<\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Mechanismen_allgemeine_Wirkungen\"><\/span>Mechanizmai ir bendras poveikis<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Fotobiomoduliacin\u0117 smegen\u0173 terapija: revoliucija kognityvin\u0117je dinamikoje<\/strong><br><em>MDPI l\u0105stel\u0117s (2024 m.)<\/em> <a href=\"https:\/\/www.mdpi.com\/2073-4409\/13\/11\/966\" target=\"_blank\" rel=\"noopener\">Visas tekstas \/ PubMed<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">PBM aktyvina citochromo c oksidaz\u0119 neuron\u0173 mitochondrijose, didina BDNF. 810 nm bangos ilgio bangos ruo\u017ee CCO suaktyv\u0117ja stipriau nei 1064 nm bangos ilgio ruo\u017ee (CCO absorbcijos smail\u0117 yra ~810 nm). Kita vertus, 1 064 nm bangos ilgis stipriau veikia Ca\u00b2\u207a kanalus. Klinikini\u0173 parametr\u0173 sutarimas: 810 nm, 250 mW\/cm\u00b2 pavir\u0161iaus, 20-60 J\/cm\u00b2, transkranialiai prefrontalin\u0117je \u017eiev\u0117je ir temporalin\u0117je skiltyje.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Smegen\u0173 PBM pasakojimo ap\u017evalga: Mechanizmai, doz\u0117s, ateities tendencijos<\/strong><br><em>PMC (Brain Photobiomodulation Review) (2018)<\/em> <a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC6041198\/\" target=\"_blank\" rel=\"noopener\">Visas tekstas \/ PubMed<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Pagrindiniai parametrai: Kortikaliniai neuronai (auginami): 25 mW\/cm\u00b2, optimali ATP gamyba - 3 J\/cm\u00b2. Didesn\u0117s doz\u0117s (10 J\/cm\u00b2) stimuliuoja ma\u017eiau, 30 J\/cm\u00b2 sukelia mitochondrij\u0173 pa\u017eeidimus. Gilesn\u0117ms smegen\u0173 sritims (bazaliniams ganglijams, smegen\u0173 kamienui sergant Parkinsono liga): (10-15 W) vietoj 3 klas\u0117s lazerio (&lt;0,5 W) rekomenduojama naudoti 4 klas\u0117s lazer\u012f (10-15 W), kad \u012f gilum\u0105 patekt\u0173 pakankamas srautas.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Alzheimer_Demenz\"><\/span>Alzheimerio liga ir demencija<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Galimas Alzheimerio ir Parkinsono lig\u0173 gydymas<\/strong><br><em>PMC (2025 M.)<\/em> <a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC12321612\/\" target=\"_blank\" rel=\"noopener\">Visas tekstas \/ PubMed<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Ikiklinikiniai tyrimai: 808-810 nm, impulsinis (40 Hz), kasdien arba 3 kartus per savait\u0119, 12 savai\u010di\u0173. Nustatytas beta amiloido suma\u017e\u0117jimas, oks. stres\u0105, neurou\u017edegim\u0105; geresni kognityviniai rodikliai gyv\u016bn\u0173 modelyje. Klinikinis tyrimas (Japonija): impulsin\u0117 810 nm \u0161viesa (40 Hz), 3 kartus per savait\u0119, 12 savai\u010di\u0173, rezultatas: reik\u0161mingai pager\u0117jo ADAS-Cog rodikliai.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Transkranijinis PBM sergant Alzheimerio liga: RCT protokolas (Japonija)<\/strong><br><em>Neurologijos ribos (2024 m.)<\/em> <a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC11258032\/\" target=\"_blank\" rel=\"noopener\">Visas tekstas \/ PubMed<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Visi\u0161kai apra\u0161yti RCT parametrai: 810 nm, impulsinis 40 Hz, 250 mW\/cm\u00b2, 20 min. per seans\u0105, 3 kartus per savait\u0119, 12 savai\u010di\u0173. Atlikus EEG matavimus nustatyta, kad pager\u0117jo alfa, beta ir gama ritmas. Pirminis galutinis rodiklis ADAS-Cog (Alzheimerio pa\u017einimo skal\u0117). Prospektyvus \u0161e\u0161\u0117linis kontroliuojamas tyrimas.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Transkranijinis PBM gerina pa\u017eintines funkcijas, potrauminio streso sutrikim\u0105 ir potrauminio sukr\u0117timo simptomus<\/strong><br><em>Journal of Neurotrauma (2025)<\/em> <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/40485299\/\" target=\"_blank\" rel=\"noopener\">Visas tekstas \/ PubMed<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">RCT, 17 pacient\u0173, patyrusi\u0173 TBI. Parametrai: 810 nm arba 1064 nm, 250 mW\/cm\u00b2, 20 J\/cm\u00b2, 10 min. per seans\u0105. Reik\u0161mingai pager\u0117jo kognityvin\u0117s funkcijos, potrauminio streso sutrikimo ir potrauminio sukr\u0117timo simptomai. Kontroliuojama placebu.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"TBI_Entgiftung_1064_nm\"><\/span>TBI ir detoksikacija (1 064 nm)<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>1064 nm PBM skatina FTB atsigavim\u0105 per neurou\u017edegimo moduliavim\u0105<\/strong><br><em>Journal of Translational Medicine (2025)<\/em> <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/41204266\/\" target=\"_blank\" rel=\"noopener\">Visas tekstas \/ PubMed<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Pel\u0117s modelis: 1064 nm \u0161viesos diodas, 25 mW\/cm\u00b2, 12 min. per dien\u0105 (= 18 J\/cm\u00b2), 14 dien\u0173. Reik\u0161mingas atsigavimas po TBI, kognityvini\u0173 ir emocini\u0173 sutrikim\u0173 su\u0161veln\u0117jimas. BDNF ir VEGF reik\u0161mingai padid\u0117jo gydomoje zonoje. Mechanizmas: mikroglijos poliarizacijos ir neurou\u017edegimo moduliavimas.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>PBM ir Glimfin\u0117 sistema: smegen\u0173 limfos drena\u017eo gerinimas<\/strong><br><em>Int. J. Mol. Sci. (2022)<\/em> <a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC8950470\/\" target=\"_blank\" rel=\"noopener\">Visas tekstas \/ PubMed<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Tyrimai su gyv\u016bnais: PBM (810 nm, 25-50 mW\/cm\u00b2) pagerina meningin\u0117s limfos tek\u0117jim\u0105, skatina beta amiloido \u0161alinim\u0105 per glimf\u0105. Terapin\u0117 reik\u0161m\u0117: smegen\u0173 detoksikacijos funkcija - svarbi Alzheimerio ligos prevencijai ir bendrai smegen\u0173 sveikatai.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Schmerzmanagement\"><\/span>Skausmo valdymas<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">PBM turi analgezin\u012f poveik\u012f, pasirei\u0161kiant\u012f keliais mechanizmais: ma\u017einant prou\u017edegimini\u0173 citokin\u0173 (TNF-\u03b1, IL-6, IL-1\u03b2) kiek\u012f, moduliuojant nociceptines C ir A\u03b4 skaidulas, didinant endorfino i\u0161siskyrim\u0105 ir gerinant vietin\u0119 mikrocirkuliacij\u0105. Pavir\u0161iniams skausmo ta\u0161kams (jautriems ta\u0161kams, trigeriniams ta\u0161kams): pakanka 630-660 nm bangos ilgio. Giliau esan\u010dioms raumen\u0173 ir skeleto strukt\u016broms (s\u0105nariams, stuburui): 780-905 nm su didesniu galios tankiu.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Parametrai<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Bangos ilgis 630-905 nm (priklausomai nuo skausmo vietos gylio)<\/li>\n\n\n\n<li>Galios tankis 40-100 mW\/cm\u00b2 (pavir\u0161inis: 40-60; giluminis: 60-100)<\/li>\n\n\n\n<li>Energijos tankis 4-10 J\/cm\u00b2 vienam ta\u0161kui (fibromialgijos atveju: iki 150 J\/cm\u00b2 visam k\u016bnui)<\/li>\n\n\n\n<li>Trukm\u0117 10-20 min. per seans\u0105<\/li>\n\n\n\n<li>Da\u017enumas 3 kartus per savait\u0119, 6-12 savai\u010di\u0173; fibromialgija: 4-6 savai\u010di\u0173 intensyvus + tolesnis steb\u0117jimas<\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Ubergreifende_Reviews\"><\/span>I\u0161samios ap\u017evalgos<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>PBM poveikis \u012fvairiems sveikatos rodikliams: bendroji RCT ap\u017evalga<\/strong><br><em>Sistemin\u0117s ap\u017evalgos (Springer) (2025)<\/em> <a href=\"https:\/\/link.springer.com\/article\/10.1186\/s13643-025-02902-3\" target=\"_blank\" rel=\"noopener\">Visas tekstas \/ PubMed<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">15 metaanalizi\u0173, &gt;9 000 pacient\u0173, 35 galutiniai rodikliai, 15 lig\u0173. Daugiausia \u012frodym\u0173 apie fibromialgij\u0105, kelio s\u0105nario osteoartrito ne\u012fgalum\u0105 ir pa\u017einimo sutrikimus. PBM protokolai labai skyr\u0117si - n\u0117ra vienodo standarto, tod\u0117l sunku palyginti. GRADE kokyb\u0117: 17% vidutin\u0117, 57% \u017eema, 26% labai \u017eema.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>PBM l\u0117tinio skausmo atveju: sistemin\u0117 RCT ap\u017evalga<\/strong><br><em>Integracini\u0173 neuromoksl\u0173 ribos (2026)<\/em> <a href=\"https:\/\/www.frontiersin.org\/journals\/integrative-neuroscience\/articles\/10.3389\/fnint.2026.1717372\/full\" target=\"_blank\" rel=\"noopener\">Visas tekstas \/ PubMed<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">14 RCT, 6 611 per\u017ei\u016br\u0117t\u0173 straipsni\u0173. Stipriausi rezultatai fibromialgijos ir periferini\u0173 neuropatij\u0173 atveju: VAS suma\u017e\u0117jimas reik\u0161mingas (p = 0,010), jautr\u016bs ta\u0161kai reik\u0161mingai suma\u017e\u0117jo (p &lt; 0,0001). Rekomenduojami neuropatinio skausmo parametrai: 660-830 nm, 40-80 mW\/cm\u00b2, 4-6 J\/cm\u00b2, 3 kartus per savait\u0119.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Fibromyalgie\"><\/span>Fibromialgija<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>PBMT veiksmingumas sergant fibromialgija: sistemin\u0117 ap\u017evalga (17 tyrim\u0173)<\/strong><br><em>MDPI taikomieji mokslai (2025)<\/em> <a href=\"https:\/\/www.mdpi.com\/2076-3417\/15\/8\/4161\" target=\"_blank\" rel=\"noopener\">Visas tekstas \/ PubMed<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">857 dalyviai. Naudoti prietaisai: \u017eemo lygio lazeris, infraraudon\u0173j\u0173 spinduli\u0173 \u0161viesos diodas, viso k\u016bno \u0161viesos lovos (NovoTHOR). Viso k\u016bno PBM (630-1 100 nm, kintamas srautas 1-150 J\/cm\u00b2) buvo bent jau lygiavertis vietiniam PBM. Mechanizmas: oksidacinio streso, mitochondrij\u0173 funkcijos ir nociceptini\u0173 signal\u0173 keli\u0173 moduliacija. Rekomendacija: Pla\u010diai paplitusi\u0173 skausmo ta\u0161k\u0173 atveju pirmenyb\u0117 teikiama viso k\u016bno metodui.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Viso k\u016bno PBM poveikis skausmui, gyvenimo kokybei ir kineziofobijai: trigubai aklas RCT, 6 m\u0117n. steb\u0117jimas<\/strong><br><em>Neuromoksl\u0173 ribos (2024)<\/em> <a href=\"https:\/\/www.frontiersin.org\/journals\/neuroscience\/articles\/10.3389\/fnins.2024.1264821\/full\" target=\"_blank\" rel=\"noopener\">Visas tekstas \/ PubMed<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">42 pacientai, NovoTHOR viso k\u016bno lova (660 + 850 nm, patentuotas galios tankis). 12 gydymo seans\u0173. Reik\u0161mingas skausmo suma\u017e\u0117jimas T2 (po gydymo), T3 (po 2 savai\u010di\u0173 steb\u0117jimo) ir T4\/T5 (3 ir 6 m\u0117n.). Viso k\u016bno PBM veiksmingiau nei selektyvus taikymas sprend\u017eia sistemin\u0119 fibromialgijos patologij\u0105.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Kniearthrose_Tendinopathie\"><\/span>Kelio osteoartritas ir tendinopatija<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>PBM kelio s\u0105nario osteoartritui gydyti: sistemin\u0117 ap\u017evalga ir metaanaliz\u0117 (10 RCT)<\/strong><br><em>Fizin\u0117 terapija (2024)<\/em> <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/38775202\/\" target=\"_blank\" rel=\"noopener\">Visas tekstas \/ PubMed<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">542 dalyviai. Veiksmingiausi parametrai: 810-830 nm, 50-100 mW\/cm\u00b2, 4-10 J\/cm\u00b2 kelio s\u0105nario erdv\u0117je, 10-20 min, 3 kartus per savait\u0119. Vidutinio stiprumo \u012frodymai d\u0117l skausmo suma\u017e\u0117jimo ir funkcinio pager\u0117jimo. Pastaba: kelio s\u0105narys yra giliau nei odos pavir\u0161ius, tod\u0117l pirmenyb\u0117 teikiama 810-850 nm (gilesnis skverbimasis), o ne 660 nm.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Neuropathischer_Schmerz\"><\/span>Neuropatinis skausmas<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Neuropatinio skausmo PBM: mechanizmai, \u012frodymai ir ateities kryptys<\/strong><br><em>Fotonikos mokslo ribos (2025 m.)<\/em> <a href=\"https:\/\/www.frontiersin.org\/journals\/photonics\/articles\/10.3389\/fphot.2025.1730347\/full\" target=\"_blank\" rel=\"noopener\">Visas tekstas \/ PubMed<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">660 nm bangos ilgis suaktyvina kitokius fotoakceptorius nei 810-850 nm. Pavir\u0161inei neuropatijai (pvz., po herpetin\u0117s neuralgijos): 660 nm, 20-50 mW\/cm\u00b2, 4-6 J\/cm\u00b2. Giliai neuropatijai (pvz., diabetinei p\u0117d\u0173 polineuropatijai): 810-830 nm, 50-100 mW\/cm\u00b2, 6-10 J\/cm\u00b2. Mechanizmas: PBM sukelia neuroprotekcij\u0105 per BDNF sintez\u0119 ir neurou\u017edegimo slopinim\u0105.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Augenheilkunde_AMD\"><\/span>Oftalmologija (AMD)<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Akims (ypa\u010d AMD) taikomos specialios dozavimo taisykl\u0117s: Tinklain\u0117s ap\u0161vita (tai, kas i\u0161 tikr\u0173j\u0173 pasiekia tinklain\u0119) yra gerokai ma\u017eesn\u0117 u\u017e prietaiso galios tank\u012f. Tokie prietaisai kaip fotobiomoduliavimo akiniai (LumiThera) spinduliuoja \u0161vies\u0105 per vyzd\u012f - tiesiai \u012f gelton\u0105j\u0105 d\u0117m\u0119. Tod\u0117l gali pakakti vos 0,3-15 \u03bcW\/cm\u00b2 tinklain\u0117s ap\u0161vitos. \u012esp\u0117jimas: netinkama doz\u0117 gali sukelti tinklain\u0117s pa\u017eeidim\u0105. Naudokite tik patvirtintus oftalmologinius PBM prietaisus!<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Parametrai<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Bangos ilgis 590 nm + 660 nm + 850 nm (keli\u0173 bangos ilgi\u0173, pvz., LIGHTSITE III)<\/li>\n\n\n\n<li>Galios tankis 0,3-15 \u03bcW\/cm\u00b2 (tinklain\u0117je); prietaiso pavir\u0161iaus plotas ~600 \u03bcW\/cm\u00b2<\/li>\n\n\n\n<li>Labai ma\u017eas energijos tankis, kruop\u0161\u010diai sukalibruotas<\/li>\n\n\n\n<li>Trukm\u0117 3-10 min. per seans\u0105, 3 kartus per savait\u0119 3-13 m\u0117n.<\/li>\n\n\n\n<li>Ilgalaikis naudojimas; tikrinkite kas 3 m\u0117nesius<\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Altersbedingte_Makuladegeneration\"><\/span>Su am\u017eiumi susijusi geltonosios d\u0117m\u0117s degeneracija<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>LIGHTSITE III: PBM (590+660+850 nm) su sausu AMD<\/strong><br><em>RETINA \u017eurnalas (2024 m.)<\/em> <a href=\"https:\/\/journals.lww.com\/retinajournal\/fulltext\/2024\/03000\/lightsite_iii__13_month_efficacy_and_safety.14.aspx\" target=\"_blank\" rel=\"noopener\">Visas tekstas \/ PubMed<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">100 pacient\u0173, 10 JAV centr\u0173, 13 m\u0117nesi\u0173. Prietaisas: \"LumiThera Valeda\" \u0161viesos tiekimo sistema. Bangos ilgiai: 590 + 660 + 850 nm paeiliui. Gydymas: 3 kartus per savait\u0119 3 m\u0117nesius, v\u0117liau gydymo ciklai kartojami. Rezultatas: +5,4 raid\u0117s reg\u0117jimo a\u0161trumo (ETDRS), palyginti su apsimestiniu, &lt;1% naujos geografin\u0117s atrofijos, palyginti su 9,8% apsimestin\u0117je rankoje - statisti\u0161kai labai reik\u0161minga.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>PBM4AMD: trumpalaikis veiksmingumas ankstyvosios ir vidutin\u0117s stadijos AMD atveju<\/strong><br><em>Akis (gamta) (2024)<\/em> <a href=\"https:\/\/www.nature.com\/articles\/s41433-024-03326-4\" target=\"_blank\" rel=\"noopener\">Visas tekstas \/ PubMed<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">38 dalyviai, 12 savai\u010di\u0173. Parametrai: 10 min. per seans\u0105, 3 kartus per savait\u0119. \u017dymiai pager\u0117jo reg\u0117jimo a\u0161trumas, kontrastinis jautrumas ir adaptacija prie tamsos. Saugumas: jokio terminio ar strukt\u016brinio \u0161alutinio poveikio tinklainei nebuvo.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>PBM naudojimas oftalmologijoje: nuo stendo iki lovos<\/strong><br><em>\"Oftalmologijos ribos\" (2024 m.)<\/em> <a href=\"https:\/\/www.frontiersin.org\/journals\/ophthalmology\/articles\/10.3389\/fopht.2024.1388602\/full\" target=\"_blank\" rel=\"noopener\">Visas tekstas \/ PubMed<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Paai\u0161kina sud\u0117ting\u0105 parametr\u0173 pad\u0117t\u012f oftalmologijoje: lemiam\u0105 reik\u0161m\u0119 turi tinklain\u0117s ap\u0161vita, o ne prietaiso galia. \u012evair\u016bs AMD tyrimai su 630 nm bangos ilgio bangomis jau parod\u0117, kad tinklain\u0117s b\u016bkl\u0117 reik\u0161mingai pager\u0117jo, esant 15 \u03bcW\/cm\u00b2. Jokio \u0161alutinio poveikio per 15 met\u0173 tinkamai dozuojant nebuvo - svarbu: naudoti tik kalibruotus medicinos prietaisus, turin\u010dius specialius akims skirtus patvirtinimus.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Onkologie_Mukositis\"><\/span>Onkologija ir mukozitas<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Burnos gleivin\u0117s u\u017edegimas yra da\u017eniausias \u016bminis chemoterapijos ir (arba) spindulin\u0117s terapijos \u0161alutinis poveikis. PBM taikomas intraoraliai burnos gleivinei kaip prevencin\u0117 priemon\u0117 (prie\u0161 v\u0117\u017eio gydym\u0105 ir jo metu). Remiantis MASCC\/ISOO gair\u0117mis (2019), PBM yra vienintel\u0117 nefarmakologin\u0117 intervencija, kuriai pateikta oficiali rekomendacija (A lygis) d\u0117l mukozito prevencijos hematopoetini\u0173 kamienini\u0173 l\u0105steli\u0173 transplantacijos metu. Bang\u0173 ilgiai ir doz\u0117s yra labiausiai standartizuoti \u0161ioje srityje.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Parametrai<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Bangos ilgis 630-660 nm (intraoralinis); 650 + 980 nm (kombinuotas intra+ekstraoralinis)<\/li>\n\n\n\n<li>Galios tankis 10-25 mW\/cm\u00b2 (MASCC\/ISOO rekomenduoja InGaAlP lazerius 10-25 mW)<\/li>\n\n\n\n<li>Energijos tankis 2-6 J\/cm\u00b2 viename gleivin\u0117s ta\u0161ke<\/li>\n\n\n\n<li>Trukm\u0117 3-5 min. vienam ta\u0161kui<br>Vartoti kasdien arba pakaitomis v\u0117\u017eio gydymo metu<\/li>\n\n\n\n<li>Da\u017enumas Kasdien chemoterapijos ir (arba) spindulin\u0117s terapijos metu; ne re\u010diau kaip 5 kartus per savait\u0119<\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Leitlinien\"><\/span>Gair\u0117s<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>MASCC\/ISOO klinikin\u0117s praktikos gair\u0117s d\u0117l PBM ir burnos mukozito<\/strong><br><em>Paramos prie\u017ei\u016bra v\u0117\u017eiui (2019 m.)<\/em> <a href=\"https:\/\/link.springer.com\/article\/10.1007\/s00520-019-04890-2\" target=\"_blank\" rel=\"noopener\">Visas tekstas \/ PubMed<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Oficiali rekomendacija (auk\u0161\u010diausias \u012frodym\u0173 lygis): Bangos ilgis 632-685 nm (He-Ne arba InGaAlP), galia 10-25 mW, energijos tankis 2-4 J\/cm\u00b2 viename taikymo ta\u0161ke, intraoraliai ant sergan\u010di\u0173 viet\u0173. Da\u017enumas: kasdien chemoterapijos metu. Taikoma: kraujodaros kamienini\u0173 l\u0105steli\u0173 transplantacijai, galvos ir kaklo chemoradioterapijai. Po 15 met\u0173 steb\u0117jimo reik\u0161mingo \u0161alutinio poveikio n\u0117ra.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Chemotherapie-induzierte_Mukositis\"><\/span>Chemoterapijos sukeltas mukozitas<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Chemo sukelto burnos mukozito prevencin\u0117 PBM: sistemin\u0117 RCT ap\u017evalga<\/strong><br><em>MDPI Biomedicina (2025)<\/em> <a href=\"https:\/\/www.mdpi.com\/2227-9059\/13\/2\/268\" target=\"_blank\" rel=\"noopener\">Visas tekstas \/ PubMed<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">13 tyrim\u0173, 828 pacientai. Naudoti parametrai: 630-660 nm InGaAlP diodinis lazeris, 10-25 mW, 2-6 J\/cm\u00b2, intraoralinis kasdien. 211 ir 128 pacientams pasirei\u0161k\u0117 mukozitas (kontrolinis ir PBM). 85% tyrim\u0173 \u0161ali\u0161kumo rizika buvo ma\u017ea. Profilaktinis PBM reik\u0161mingai prana\u0161esnis u\u017e reaktyv\u0173 gydym\u0105.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>PBM i\u0161ankstinis pasirengimas burnos gleivin\u0117s u\u017edegimo gydymui: dvigubai aklas RCT<\/strong><br><em>BMC Oral Health (2025)<\/em> <a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC11800611\/\" target=\"_blank\" rel=\"noopener\">Visas tekstas \/ PubMed<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">45 pacientai, 3 grup\u0117s. 2 grup\u0117: intraoralinis 650 nm (4 J\/cm\u00b2). 3 grup\u0117: intraoralinis 650 nm + ekstraoralinis 980 nm. Abiejose intervencin\u0117se grup\u0117se pasteb\u0117ta reik\u0161minga mukozito ir kserostomijos prevencija. Rezultatas: Raudonosios + infraraudonosios \u0161viesos (650 + 980 nm) derinys maksimaliai veiksmingas siekiant visi\u0161kai padengti burnos ertm\u0119.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Kopf-Hals-Karzinome_Strahlentherapie\"><\/span>Galvos ir kaklo v\u0117\u017eys ir radioterapija<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>PBM, skirtas galvos ir kaklo v\u0117\u017eio sukeltam burnos mukozitui gydyti: 14 RCT metaanaliz\u0117<\/strong><br><em>Galvos ir kaklo (Wiley) (2024)<\/em> <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/38265122\/\" target=\"_blank\" rel=\"noopener\">Visas tekstas \/ PubMed<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">869 pacientai. Parametr\u0173 analiz\u0117: He-Ne ir InGaAlP lazeris (630-660 nm), 10-25 mW, 2-6 J\/cm\u00b2, kasdienis naudojimas radioterapijos metu dav\u0117 geriausius rezultatus. Santykinis mukozito rizikos suma\u017e\u0117jimas: RR = 0,49 (p = 0,04) nuo 2 savait\u0117s. Skausmo suma\u017e\u0117jimas: WMD = -1,09 (p &lt; 0,00001). Labai reik\u0161mingas veiksmingumas per 7 radioterapijos savaites.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Immunsystem_Entzundung\"><\/span>Imunin\u0117 sistema ir u\u017edegimas<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">PBM veikia imunin\u0119 sistem\u0105 priklausomai nuo konteksto: Jis veikia prie\u0161u\u017edegimi\u0161kai (ma\u017eina TNF-\u03b1, IL-6, IL-1\u03b2; skatina M2 makrofag\u0173 poliarizacij\u0105), o sveikame audinyje - stimuliuoja. Imunomoduliacinis poveikis buvo \u012frodytas optiniame lange (650-950 nm), o doz\u0117s koridorius - 1-10 J\/cm\u00b2. Svarbu: \u0161ios doz\u0117s yra gerokai ma\u017eesn\u0117s nei naudojant raumenims - imunin\u0117 sistema reaguoja jautriau.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Parametrai<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Bangos ilgis 650-950 nm (pla\u010diausias veiksmingas spektras; rekomenduojamas 660 + 850 nm derinys)<\/li>\n\n\n\n<li>Galios tankis 20-80 mW\/cm\u00b2<\/li>\n\n\n\n<li>Energijos tankis 1-10 J\/cm\u00b2 (imunomoduliacija)<br>Didesn\u0117s doz\u0117s gali tur\u0117ti imunosupresin\u012f poveik\u012f<\/li>\n\n\n\n<li>Trukm\u0117 5-15 min. per seans\u0105<\/li>\n\n\n\n<li>3 kartus per savait\u0119; \u016bminio u\u017edegimo atveju pirm\u0105j\u0105 savait\u0119 kasdien<\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Immunmodulation\"><\/span>Imunomoduliacija<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Imunomoduliacinis PBM poveikis: i\u0161sami ap\u017evalga<\/strong><br><em>Lazeriai medicinos moksle (2025)<\/em> <a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC11991943\/\" target=\"_blank\" rel=\"noopener\">Visas tekstas \/ PubMed<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Optimal\u016bs imunomoduliacijos parametrai: 650-950 nm, 20-80 mW\/cm\u00b2, 1-10 J\/cm\u00b2. PBM veikia dendritines l\u0105steles (migracija, citokin\u0173 gamyba), skatina makrofag\u0173 M2 poliarizacij\u0105 ir reguliuoja T l\u0105steli\u0173 atsak\u0105. Svarbi i\u0161vada: tik 1 J\/cm\u00b2 pakanka i\u0161matuojamam imunologiniam poveikiui - tai gerokai ma\u017eesn\u0117s nei rekomenduojamos raumen\u0173 ir kaul\u0173 poveikio doz\u0117s.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>PBM terapijos veiksmingumas gydant skausm\u0105 ir u\u017edegim\u0105: literat\u016bros ap\u017evalga<\/strong><br><em>PMC (2023 M.)<\/em> <a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC10094541\/\" target=\"_blank\" rel=\"noopener\">Visas tekstas \/ PubMed<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">PBM 600-1 070 nm, energijos tankis 1-150 J\/cm\u00b2. Optimalus u\u017edegimo slopinimas: 780-950 nm, 40-80 mW\/cm\u00b2, 4-10 J\/cm\u00b2, 3 kartus per savait\u0119. Viso k\u016bno PBM parod\u0117 sistemin\u012f imunin\u012f poveik\u012f: pager\u0117jo miego kokyb\u0117, rytinis sustingimas, suma\u017e\u0117jo raumen\u0173 m\u0117\u0161lungis, psichologiniai veiksniai. Ypa\u010d aktualu sergant l\u0117tin\u0117mis u\u017edegimin\u0117mis sistemin\u0117mis ligomis (pvz., fibromialgija, RA).<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>\u0160viesos parametr\u0173 ir PBM veiksmingumo ap\u017evalga (Hamblin, Harvardas)<\/strong><br><em>J. Biomed. Optics (PMC) (2021)<\/em> <a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC8355782\/\" target=\"_blank\" rel=\"noopener\">Visas tekstas \/ PubMed<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Pagrindinis darbas parametrams nustatyti (Hamblin\/Harvard). Pagrindinis teiginys: n\u0117ra visuotinio sutarimo d\u0117l optimali\u0173 parametr\u0173 - galios tankis &lt; 100 mW\/cm\u00b2 ir energijos tankis 4-10 J\/cm\u00b2 tiksliniame audinyje laikomi bendru sutarimu konservatyvioms rekomendacijoms. Dvifazis atsakas \u012f doz\u0119 (Arndt-Schulz): l\u0105steli\u0173 stimuliavimas 0,5-10 J\/cm\u00b2, slopinimas vir\u0161 ~30 J\/cm\u00b2. Audiniams, kuriuose yra daug mitochondrij\u0173 (raumenys, nervai, \u0161irdis, smegenys), reikia daugiau energijos nei audiniams, kuriuose yra ma\u017eai mitochondrij\u0173 (oda, sausgysl\u0117s, kremzl\u0117s).<\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Klinische_Empfehlungen\"><\/span>Klinikin\u0117s rekomendacijos<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Fotobiomoduliacija yra pirmasis neinvazin\u0117s terapijos b\u016bdas, kurio klinikinis veiksmingumas \u012frodytas bent 7 skirtingose medicinos srityse. \u012erodym\u0173 stiprumas skiriasi: Patikimiausi duomenys yra apie burnos gleivin\u0117s u\u017edegim\u0105 (MASCC\/ISOO gair\u0117s), \u017eaizd\u0173 gijim\u0105 (metaanaliz\u0117s LoE I) ir raumen\u0173 regeneracij\u0105 sporte. Smegen\u0173 ir (arba) neurologijos bei AMD sritys yra labai perspektyvios, ta\u010diau vis dar tobulinamos.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Allgemeine_Dosierungsregeln_Konsensus\"><\/span>Bendrosios dozavimo taisykl\u0117s (bendru sutarimu)<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Absorbuota doz\u0117<\/strong><br>5-50 d\u017eauli\u0173 per sesij\u0105 (rekomenduojama: ~25 J)<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Bangos ilgis vienam taikiniui<\/strong><br>660 nm - odai \/ pavir\u0161iui<br>810-850 nm - raumenims, s\u0105nariams ir giliesiems audiniams<br>1 050-1 064 nm - smegenys<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Galios tankis gylyje<\/strong><br>Oda 6-50 mW\/cm\u00b2<br>Raumenys 50-100 mW\/cm\u00b2<br>Smegenys (transkranijinis) 25-285 mW\/cm\u00b2<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Steb\u0117kite dvifazi\u0161kum\u0105<\/strong><br>Didesn\u0117s doz\u0117s n\u0117ra automati\u0161kai geresn\u0117s.<br>- Oda: ne daugiau kaip 20 J\/cm\u00b2<br>- Neuronai: ne daugiau kaip 10 J\/cm\u00b2 ant tikslinio audinio<br>- raumenims: ne daugiau kaip 30-50 J\/cm\u00b2<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Kombinuotieji prietaisai<\/strong> - 660 + 850 nm - pla\u010diausias spektras; reikia ~ 50% daugiau gydymo laiko<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Gydymo intervalas<\/strong><br>Kasdien iki 3\u00d7 per savait\u0119; rekomenduojama daryti pertrauk\u0105 kas 1-2 dienas, kad l\u0105stel\u0117s atsigaut\u0173<\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Evidenzstarke_nach_Bereich\"><\/span>\u012erodym\u0173 stiprumas pagal sritis<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Labai stiprus (LoE I, WALT\/MASCC gair\u0117s)<\/strong><br>- V\u0117\u017eio sukeltas mukozitas<br>- \u017daizd\u0173 gijimas<br>- Kolagenas \/ oda<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Stiprus (LoE I, metaanaliz\u0117s)<\/strong><br>- Raumen\u0173 regeneracija<br>- Fibromialgija<br>- AMD<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Vidutinio sunkumo (LoE II, RCT)<\/strong><br>- Kelio osteoartritas<br>- neuropatinis skausmas<br>- Pa\u017einimas (transkranijinis)<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Ankstyvoji (ikiklinikin\u0117\/ bandomoji)<\/strong><br>- Detoksikacija, limfin\u0117 sistema<br>- Ilgalaikis i\u0161gyvenamumas po v\u0117\u017eio<br>- 1 064 nm giliosios smegen\u0173 strukt\u016bros<\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Kontakt_zu_PBM-Anwendern_%E2%80%93_Arzte_Kliniken\"><\/span>Ry\u0161iai su PBM naudotojais - gydytojais \/ klinikomis<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Augenheilkunde_%E2%80%93_Trockene_AMD_Makuladegeneration\"><\/span>Oftalmologija - sausoji AMD (geltonosios d\u0117m\u0117s degeneracija)<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">Tai klini\u0161kai pa\u017eangiausia ir teis\u0117s aktais saugiausia sritis. \u012erenginys&nbsp;<strong>Valeda (LumiThera)<\/strong>&nbsp;turi CE sertifikat\u0105 ir yra patvirtintas Europoje nuo 2018 m., o FDA patvirtintas nuo 2024 m. lapkri\u010dio m\u0117n.<\/p>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th>Teik\u0117jas<\/th><th>Vieta<\/th><th>Nuoroda<\/th><\/tr><\/thead><tbody><tr><td><strong>Geltonosios d\u0117m\u0117s tinklain\u0117s centras<\/strong>&nbsp;(Prof. Dr. Hakanas Kaymakas - vienas i\u0161 labiausiai patyrusi\u0173 naudotoj\u0173 pasaulyje, atliekantis ~10 % vis\u0173 PBM proced\u016br\u0173 visame pasaulyje)<\/td><td>Diuseldorfas<\/td><td><a href=\"https:\/\/augenchirurgie.clinic\/behandlungen\/photobiomodulation\" target=\"_blank\" rel=\"noopener\">oftalmkochirurgija.klinika<\/a><\/td><\/tr><tr><td><strong>Oftalmologas Witten<\/strong>&nbsp;(Dr. Riha) - viena pirm\u0173j\u0173 praktik\u0173 Vokietijoje<\/td><td>Witten \/ NRW<\/td><td><a href=\"https:\/\/www.augenarzt-witten.de\/photobiomodulation\/\" target=\"_blank\" rel=\"noopener\">augenarzt-witten.de<\/a><\/td><\/tr><tr><td><strong>Miuncheno oftalmologas<\/strong>&nbsp;(Dr. Augstenas)<\/td><td>Miunchenas<\/td><td><a href=\"https:\/\/www.augenarzt-muc.de\/netzhaut\/behandlung\/valeda\/\" target=\"_blank\" rel=\"noopener\">oftalmologas-muc.de<\/a><\/td><\/tr><tr><td><strong>Oftalmologai Gerl ir kolegos<\/strong>&nbsp;(Valedos programa)<\/td><td>Miunchenas<\/td><td><a href=\"https:\/\/www.augenklinik.de\/behandlung\/valeda\" target=\"_blank\" rel=\"noopener\">eyeclinic.com<\/a><\/td><\/tr><tr><td><strong>Dr. Riha oftalmologija<\/strong><\/td><td>Viena \/ AT<\/td><td><a href=\"https:\/\/dr-riha.com\/photobiomodulation\/\" target=\"_blank\" rel=\"noopener\">dr-riha.com<\/a><\/td><\/tr><tr><td><strong>Berno oftalmologai<\/strong>&nbsp;(CH)<\/td><td>Bernas \/ CH<\/td><td><a href=\"https:\/\/www.augenaerzte-bern.ch\/leistungen\/photobiomodulation-bei-altersbedingter-makuladegeneration\/\" target=\"_blank\" rel=\"noopener\">oftalmologai-bern.ch<\/a><\/td><\/tr><tr><td><strong>Berno aki\u0173 klinika<\/strong>&nbsp;(Prof. Garwegas)<\/td><td>Bernas \/ CH<\/td><td><a href=\"https:\/\/augenklinik-bern.ch\/fachpublikum\/amd-sprechstunde\/\" target=\"_blank\" rel=\"noopener\">eye-clinic-bern.ch<\/a><\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Pastaba:<\/strong>\u00a0I\u0161laid\u0173 paprastai nepadengia privalomasis sveikatos draudimas (IGeL).<br>Savo svetain\u0117je \"LumiThera\" si\u016blo kit\u0173 Valedos centr\u0173 paie\u0161kos sistem\u0105.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Onkologie_%E2%80%93_Orale_Mukositis_Chemo-Strahlentherapiefolge\"><\/span>Onkologija - burnos gleivin\u0117s u\u017edegimas (chemoterapijos ir (arba) spindulin\u0117s terapijos pasekm\u0117)<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">Burnos gleivin\u0117s u\u017edegimo profilaktikai ir gydymui skirtos PBM yra pagr\u012fstos gair\u0117mis (MASCC\/ISOO) ir vis da\u017eniau \u012ftraukiamos \u012f onkologinio palaikomojo gydymo programas. Pirm\u0105 kart\u0105 Europos klinikin\u0117s gair\u0117s buvo parengtos 2025\/2026 m.<\/p>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th>Teik\u0117jas<\/th><th>U\u017euomina<\/th><th>Nuoroda<\/th><\/tr><\/thead><tbody><tr><td><strong>rj-laser.com<\/strong>&nbsp;- Dant\u0173 lazerin\u0117s terapijos platforma su klinikiniais protokolais d\u0117l mukozito<\/td><td>Specialist\u0173 portalas DE\/AT\/CH<\/td><td><a href=\"https:\/\/rj-laser.com\/de\/lasertherapie-mukositis-chemotherapieinduziert\" target=\"_blank\" rel=\"noopener\">rj-laser.com<\/a><\/td><\/tr><tr><td><strong>Informacijos apie v\u0117\u017e\u012f tarnyba (KID)<\/strong><\/td><td>Primygtinai rekomenduoja PBM kaip mukozito palaikomojo gydymo galimyb\u0119<\/td><td><a href=\"https:\/\/www.krebsinformationsdienst.de\/fileadmin\/pdf-dateien\/informationsblaetter\/iblatt-mukositis-bei-krebs.pdf\" target=\"_blank\" rel=\"noopener\">krebsinformationsdienst.de<\/a><\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<p class=\"wp-block-paragraph\">Konkre\u010dios klinikos Vokietijoje, kurios reguliariai si\u016blo PBM d\u0117l mukozito, retai apie tai ai\u0161kiai skelbia pacient\u0173 interneto svetain\u0117se. \u0160is gydymas paprastai taikomas kaip dant\u0173 palaikomojo gydymo dalis dideliuose onkologijos centruose (pvz., universitetin\u0117se ligonin\u0117se).<br>Patartina kreiptis \u012f gydant\u012f onkologijos centr\u0105 arba veido ir \u017eandikauli\u0173 chirurg\u0105.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Dermatologie_%E2%80%93_Haut_Wundheilung_Akne_Psoriasis\"><\/span>Dermatologija - oda, \u017eaizd\u0173 gijimas, spuogai, psoriaz\u0117<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">PBM, naudojant LED \u0161viesos terapij\u0105, taikoma daugelyje dermatologijos kabinet\u0173 ir estetin\u0117s medicinos klinik\u0173.<\/p>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th>Teik\u0117jas<\/th><th>Vieta<\/th><th>Nuoroda<\/th><\/tr><\/thead><tbody><tr><td><strong>Dermatologija Dr. Friedl<\/strong>&nbsp;- LED \u0161viesos terapija (Medisol\u00ae) aknei, vitiligo, psoriazei, odos sen\u0117jimui, baltajam odos v\u0117\u017eiui gydyti (PDT)<\/td><td>Austrija<\/td><td><a href=\"https:\/\/www.dermatologie-friedl.de\/leistungen\/aesthetische-medizin\/led-lichttherapie-mit-medisol-lampe\" target=\"_blank\" rel=\"noopener\">dermatologija-friedl.com<\/a><\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<p class=\"wp-block-paragraph\">Be to, daugelis estetin\u0117s dermatologijos kabinet\u0173 ir lazeri\u0173 centr\u0173 Vokietijoje naudoja PBM (pvz., \u201eFotona\u201c sistemas). Rekomenduojame ie\u0161koti \u201eLED \u0161viesos terapijos dermatologija\u201c arba \"PBM dermatologas\", nurodant vietov\u0119.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Zahnmedizin_MKG-Chirurgie\"><\/span>Odontologija \/ veido ir \u017eandikauli\u0173 chirurgija<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">PBM pla\u010diai naudojamas odontologijoje, pvz., nuo temporomandibulinio s\u0105nario skausmo (CMD), pooperacini\u0173 \u017eaizd\u0173 gijimo, implant\u0173 ir gleivin\u0117s u\u017edegimo. Ortodontai naudoja&nbsp;<strong>OrthoPulse\u00ae prietaisas<\/strong>&nbsp;dant\u0173 jud\u0117jimui pagreitinti (taikoma savaranki\u0161kai, apie 600 eur\u0173).<\/p>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th>Teik\u0117jas \/ portalas<\/th><th>U\u017euomina<\/th><th>Nuoroda<\/th><\/tr><\/thead><tbody><tr><td><strong>ZWP internete<\/strong>&nbsp;- KFO-PBM ap\u017evalga<\/td><td>Specializuotas portalas<\/td><td><a href=\"https:\/\/www.zwp-online.info\/zwpnews\/wirtschaft-und-recht\/recht\/photobiomodulation-in-der-kieferorthopadie\" target=\"_blank\" rel=\"noopener\">zwp-online.info<\/a><\/td><\/tr><tr><td><strong>\"Fotona\" lazerin\u0117s sistemos<\/strong>&nbsp;(Galima pardav\u0117jo \/ klinikos paie\u0161ka)<\/td><td>Odontologijos ir medicinos PBM, \"LightWalker<\/td><td><a href=\"https:\/\/www.fotona.com\/de\/treatments\/6496\/photobiomodulation-und-schmerzbehandlung\/\" target=\"_blank\" rel=\"noopener\">fotona.com<\/a><\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Neurologie_Psychiatrie_%E2%80%93_Alzheimer_TBI_Depression_fruhe_Phase\"><\/span>Neurologija \/ psichiatrija - Alzheimerio liga, TBI, depresija (ankstyvoji stadija)<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">\u0160ioje srityje vis dar atliekami klinikiniai tyrimai. Reguliariai patvirtintos pacient\u0173 aptarnavimo paslaugos Vokietijoje vis dar retos, ta\u010diau jau yra pirm\u0173j\u0173 centr\u0173 ir tyrim\u0173.<\/p>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th>Teik\u0117jas \/ portalas<\/th><th>U\u017euomina<\/th><th>Nuoroda<\/th><\/tr><\/thead><tbody><tr><td><strong>PBM-Photobiomodulation.eu<\/strong>&nbsp;- Europos informacijos portalas su praktine ap\u017evalga<\/td><td>DACH regionas<\/td><td><a href=\"https:\/\/pbm-photobiomodulation.eu\/PBM\" target=\"_blank\" rel=\"noopener\">pbm-photobiomodulation.eu<\/a><\/td><\/tr><tr><td><strong>Neurofeedback Liuksemburgas<\/strong>&nbsp;- informuoja apie neurologines PBM programas.<\/td><td>LU\/DACH<\/td><td><a href=\"https:\/\/neurofeedback-luxembourg.com\/de\/photobiomodulation-ein-umfassender-leitfaden-fur-lichttherapievorteile\/\" target=\"_blank\" rel=\"noopener\">neurofeedback-luxembourg.com<\/a><\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Allgemeine_Suchwerkzeuge\"><\/span>Bendrieji paie\u0161kos \u012frankiai<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Gamintojas \"LumiThera\" savo svetain\u0117je si\u016blo\u00a0<strong>Vietos paie\u0161ka<\/strong>\u00a0Valedos praktikos:\u00a0<a href=\"https:\/\/www.lumithera.com\/\" target=\"_blank\" rel=\"noopener\">lumithera.com<\/a><\/li>\n\n\n\n<li>Portalas\u00a0<strong>pbm-photobiomodulation.eu<\/strong>\u00a0Europos praktikos s\u0105ra\u0161ai<\/li>\n\n\n\n<li>Svetain\u0117\u00a0<strong>Pasaulin\u0117 lazerio terapijos asociacija (WALT)<\/strong>\u00a0si\u016blo pasaulin\u0119 terapeuto paie\u0161k\u0105<\/li>\n<\/ul>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Svarbi pastaba:<\/strong>\u00a0Daugumos PBM indikacij\u0173 (i\u0161skyrus palaikom\u0105j\u0105 onkologij\u0105 kai kuriuose centruose) i\u0161laid\u0173 kompensavimas i\u0161 privalomojo sveikatos draudimo fond\u0173 Vokietijoje dar nereglamentuojamas.<br>PBM da\u017eniausiai naudojamas kaip\u00a0<strong>IGeL paslauga<\/strong>\u00a0s\u0105skaitos i\u0161ra\u0161omos priva\u010diai.<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<div style=\"height:100px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n\n<p class=\"wp-block-paragraph\"><em>Dokumentas parengtas remiantis PubMed, PMC, Frontiers, MDPI, Springer ir Nature recenzuota literat\u016bra nuo 2019 m. iki 2026 m. vasario m\u0117n. <\/em><br>Parodyta <em>Parametrai paimti i\u0161 klinikini\u0173 tyrim\u0173 ir WALT\/MASCC rekomendacij\u0173.<\/em><\/p>\n\n\n\n<div style=\"height:100px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n\n<blockquote class=\"wp-block-quote is-layout-flow wp-block-quote-is-layout-flow\">\n<p class=\"wp-block-paragraph\">Visas turinys buvo kruop\u0161\u010diai i\u0161tirtas ir atspindi dabartin\u012f (2026 02 02) paskelbt\u0105 \u017eini\u0173 lyg\u012f. Jis skirtas tik informacijos tikslais ir nepakei\u010dia profesionalios gydytojo konsultacijos.<br><br>Susij\u0119 tyrimai suteikia gydytojui papildomos medicinin\u0117s ir mokslin\u0117s informacijos.<\/p>\n<\/blockquote>","protected":false},"excerpt":{"rendered":"<p><span class=\"span-reading-time rt-reading-time\" style=\"display: block;\"><span class=\"rt-label rt-prefix\">Skaitymo laikas<\/span> <span class=\"rt-time\"> 12<\/span> <span class=\"rt-label rt-postfix\">minut\u0117s<\/span><\/span>Umfassende Studien\u00fcbersicht 2023\u20132025 Einleitung Photobiomodulation (PBM), auch bekannt als Low-Level-Lasertherapie (LLLT), ist eine nicht-invasive therapeutische Methode, die Licht bestimmter Wellenl\u00e4ngen nutzt, um biologische Prozesse in lebendem Gewebe zu stimulieren.Prim\u00e4rer Mechanismus ist die Absorption von Photonen durch den mitochondrialen Photoakzeptor Cytochrom-c-Oxidase (CCO), was die ATP-Synthese steigert, reaktive Sauerstoffspezies moduliert und eine Kaskade zellul\u00e4rer Regenerationsprozesse anst\u00f6\u00dft. Das&hellip;&nbsp;<a href=\"https:\/\/csiag.eu\/lt\/blog\/2026\/02\/18\/photobiomodulation-pbm\/\" rel=\"bookmark\">Skaityti daugiau \"<span class=\"screen-reader-text\">Fotobiomoduliacija (PBM)<\/span><\/a><\/p>","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_lmt_disableupdate":"","_lmt_disable":"","neve_meta_sidebar":"","neve_meta_container":"","neve_meta_enable_content_width":"","neve_meta_content_width":0,"neve_meta_title_alignment":"","neve_meta_author_avatar":"","neve_post_elements_order":"","neve_meta_disable_header":"","neve_meta_disable_footer":"","neve_meta_disable_title":"","footnotes":""},"categories":[1],"tags":[],"class_list":["post-12784","post","type-post","status-publish","format-standard","hentry","category-uncategorized"],"modified_by":"Achim Goerner","_links":{"self":[{"href":"https:\/\/csiag.eu\/lt\/wp-json\/wp\/v2\/posts\/12784","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/csiag.eu\/lt\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/csiag.eu\/lt\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/csiag.eu\/lt\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/csiag.eu\/lt\/wp-json\/wp\/v2\/comments?post=12784"}],"version-history":[{"count":0,"href":"https:\/\/csiag.eu\/lt\/wp-json\/wp\/v2\/posts\/12784\/revisions"}],"wp:attachment":[{"href":"https:\/\/csiag.eu\/lt\/wp-json\/wp\/v2\/media?parent=12784"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/csiag.eu\/lt\/wp-json\/wp\/v2\/categories?post=12784"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/csiag.eu\/lt\/wp-json\/wp\/v2\/tags?post=12784"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}